Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Quick take on Which Is Cheaper Index Funds Or Mutual Funds, focusing on fee comparisons and how cost differences impact overall performance.
22,925 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
A practical guide to interpreting FRPH's Q2 2025 earnings transcript. Learn what to watch, how numbers fit the story,...
Oil prices climb as inflation concerns linger, prompting the Fed to hold rates steady for now. The impact rising fuel...
Oil shocks aren’t just headlines. This guide breaks down five real ways a $100 oil price affects your wallet and your...
Bitcoin dipped over the weekend, but traders rotated into infrastructure-focused bets as the Bitcoin Hyper presale su...
Icahn Enterprises just added a sizable stake in Centuri Holdings, signaling a continued conviction in North America's...
A major security misconfiguration at Anthropic left internal assets, including notes on an unreleased model and CEO r...
Dogecoin broke through a multi-session resistance with a heavy volume burst, prompting traders to eye the next hurdle...
A timely wealth story shows how Naomi Osaka's boundary-first approach translates into smart money moves for 2026, urg...
Market pullbacks can wipe out gains, but some AI leaders actually gain momentum as fear rises. Learn how to spot a st...
A tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
A new warning about looming physical oil shortages is sending ripples through energy stocks. This article explains wh...